CTNA2 Polyclonal Antibody
- Catalog No.:YN0562
- Applications:WB;ELISA
- Reactivity:Human;Mouse
- Target:
- CTNA2
- Fields:
- >>Hippo signaling pathway;>>Adherens junction;>>Leukocyte transendothelial migration;>>Bacterial invasion of epithelial cells;>>Pathways in cancer;>>Endometrial cancer;>>Gastric cancer;>>Arrhythmogenic right ventricular cardiomyopathy
- Gene Name:
- CTNNA2 CAPR
- Protein Name:
- Catenin alpha-2 (Alpha N-catenin) (Alpha-catenin-related protein)
- Human Gene Id:
- 1496
- Human Swiss Prot No:
- P26232
- Mouse Swiss Prot No:
- Q61301
- Immunogen:
- Synthesized peptide derived from part region of human protein
- Specificity:
- CTNA2 Polyclonal Antibody detects endogenous levels of protein.
- Formulation:
- Liquid in PBS containing 50% glycerol, and 0.02% sodium azide.
- Source:
- Polyclonal, Rabbit,IgG
- Dilution:
- WB 1:500-2000 ELISA 1:5000-20000
- Purification:
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
- Concentration:
- 1 mg/ml
- Storage Stability:
- -15°C to -25°C/1 year(Do not lower than -25°C)
- Observed Band(KD):
- 104kD
- Background:
- similarity:Belongs to the vinculin/alpha-catenin family.,
- Function:
- similarity:Belongs to the vinculin/alpha-catenin family.,
- Subcellular Location:
- Cell membrane ; Peripheral membrane protein ; Cytoplasmic side . Cytoplasm . Cytoplasm, cytoskeleton . Cell junction, adherens junction . Cell projection, axon . Nucleus .
- Expression:
- Expressed in neural tissues, with strongest expression in fetal and adult brain. Expressed in the developing cortical plate and marginal zone of 20-week-old human fetal brain.
- June 19-2018
- WESTERN IMMUNOBLOTTING PROTOCOL
- June 19-2018
- IMMUNOHISTOCHEMISTRY-PARAFFIN PROTOCOL
- June 19-2018
- IMMUNOFLUORESCENCE PROTOCOL
- September 08-2020
- FLOW-CYTOMEYRT-PROTOCOL
- May 20-2022
- Cell-Based ELISA│解您多样本WB检测之困扰
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-ACETYL-PROTEIN
- July 13-2018
- CELL-BASED-ELISA-PROTOCOL-FOR-PHOSPHO-PROTEIN
- July 13-2018
- Antibody-FAQs